MedTrace Logo

Intraarticular Gold Microparticles for Hip Osteoarthritis

NCT06186115 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-01-30

No results posted yet for this study

Summary

In a pilot study, the investigators recently showed that intraarticular metallic gold microparticles reduce knee osteoarthritis pain for up to two years and found associated significant proteomic changes in serum and synovial fluid within eight weeks. This study aim to evaluate the outcome after intra-articular injection of gold microparticles for hip osteoarthritis.

Conditions

  • Osteoarthritis, Hip

Interventions

COMBINATION_PRODUCT

Gold

Intra articular

Sponsors & Collaborators

  • Aalborg University Hospital

    collaborator OTHER

  • Northern Orthopaedic Division, Denmark

    lead OTHER

Principal Investigators

  • Sten Rasmussen, MD PhD · Northern ODD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-04
Primary Completion
2024-04-01
Completion
2024-05-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06186115 on ClinicalTrials.gov